Item 5.07 Submission of Matters to a Vote of Security Holders. (a) Aurinia Pharmaceuticals Inc. (the "Corporation") held its annual general meeting of shareholders virtually on June 3, 2026 (the "2026 Meeting"). (b) The following proposals were voted upon at the 2026 Meeting and the final voting results with respect to each such proposal are set forth below: Proposal 1: Based upon the following votes, the shareholders elected Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina S. Nova to serve as members of the Corporation's board of directors until the annual general meeting of shareholders to be held in 2027. Number of Shares Percentage of Votes Cast Nominee For Withheld Broker Non-Votes For Against Withheld/Abstain Kevin Tang 68,889,411 2,434,090 16,049,984 96.59% 0.00% 3.41% Jeffrey Bailey 67,990,723 3,332,778 16,049,984 95.33% 0.00% 4.67% Kathy Goetz 68,840,807 2,482,694 16,049,984 96.52% 0.00% 3.48% Craig Johnson 61,694,786 9,628,715 16,049,984 86.50% 0.00% 13.50% Tina S. Nova 61,972,942 9,350,560 16,049,983 86.89% 0.00% 13.11% Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Corporation's independent registered public accounting firm until the annual general meeting of shareholders to be held in 2027 or until a successor is appointed. Number of Shares Percentage of Votes Cast For Withhold Broker Non-Votes For Against Withheld/Abstain 77,785,132 9,488,350 3 89.14% 0.00% 10.86% Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a “say on pay” resolution regarding the Corporation's executive compensation. Number of Shares Percentage of Votes Cast For Against Abstain Broker Non-Votes For Against Withheld/Abstain 66,398,971 4,315,143 609,384 16,049,987 93.10% 6.05% 0.85%
AUPH Aurinia Pharmaceuticals Inc. - 8-K
Accession
0001600620-26-0000535.079.01
Item 5.07 - Submission of Matters to a Vote of Security Holders
269 words
Item 9.01 - Financial Statements and Exhibits
29 words
Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)